Amneal Pharmaceuticals, Inc. 10-K filing
Filed 2026-02-27 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001723128-26-000011
- Form type
- 10-K
- CIK
- 0001723128
- Primary document
- https://www.sec.gov/Archives/edgar/data/1723128/000172312826000011/amrx-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Amneal Pharmaceuticals, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $3.0B | - | - |
| Cost Of Revenue | $1.9B | - | - |
| Gross Profit | $1.1B | - | - |
| Operating Income | $394.1M | - | - |
| Net Income | $72.1M | - | - |
| Eps Basic | 0.23 | - | - |
| Eps Diluted | 0.22 | - | - |
| Cash And Equivalents | $282.0M | - | - |
| Total Assets | $3.7B | - | - |
| Shareholders Equity | $-70.8M | - | - |
| Operating Cash Flow | $340.0M | - | - |
| Capital Expenditures | $70.1M | - | - |